Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Osteoblastoma D018215 1 associated lipids
Erythromelalgia D004916 1 associated lipids
Fibromuscular Dysplasia D005352 2 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Drowning D004332 2 associated lipids
Jejunal Diseases D007579 3 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Radiculopathy D011843 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
González-Correa JA et al. Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood. 2005 May-Jun Platelets pmid:16011961
Wenzel F et al. Determination of thromboxane formation, soluble CD40L release and thrombopoietin clearance in apheresis platelet concentrates. 2012 Platelets pmid:21806498
Siewiera K et al. Long-term untreated streptozotocin-diabetes leads to increased expression and elevated activity of prostaglandin H2 synthase in blood platelets. 2016 Platelets pmid:26325148
Ozyazgan I et al. Eicosanoids and inflammatory cells in frostbitten tissue: prostacyclin, thromboxane, polymorphonuclear leukocytes, and mast cells. 1998 Plast. Reconstr. Surg. pmid:9623831
Heggers JP et al. Evaluation of burn blister fluid. 1980 Plast. Reconstr. Surg. pmid:6770396
Dernell WS et al. Thromboxane as a measure of cutaneous vascular damage following irradiation. 1994 Plast. Reconstr. Surg. pmid:8208814
Ono I et al. A study on the effectiveness of a thromboxane synthetase inhibitor (OKY-046) in increasing the survival length of skin flaps. 1990 Plast. Reconstr. Surg. pmid:2147062
Feng LJ et al. Vasoactive prostaglandins in the impending no-reflow state: evidence for a primary disturbance in microvascular tone. 1988 Plast. Reconstr. Surg. pmid:3163151
Robson MC et al. A new explanation for the progressive tissue loss in electrical injuries. 1984 Plast. Reconstr. Surg. pmid:6422484
Ysrael MC and Croft KD Inhibition of leukotriene and platelet activating factor synthesis in leukocytes by the sesquiterpene lactone scandenolide. 1990 Planta Med. pmid:2168055
Gabler NK et al. Dietary onion intake as part of a typical high fat diet improves indices of cardiovascular health using the mixed sex pig model. 2006 Plant Foods Hum Nutr pmid:17123162
Bowen RS et al. Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition. 2005 Placenta pmid:15850645
Howarth SR et al. Role of thromboxane A2 in the vasoconstrictor response to endothelin-1, angiotensin II and 5-hydroxytryptamine in human placental vessels. 1995 Placenta pmid:8710799
Zhao S et al. Predominant basal directional release of thromboxane, but not prostacyclin, by placental trophoblasts from normal and preeclamptic pregnancies. 2008 Placenta pmid:17936899
Wilkes BM et al. Reduced thromboxane receptor affinity and vasoconstrictor responses in placentae from diabetic pregnancies. 1994 Placenta pmid:7886025
Sorem KA and Siler-Khodr TM Placental prostanoid release in severe intrauterine growth retardation. 1995 Placenta pmid:8570572
Iioka H et al. Studies on placental inhibition of platelet aggregation: a comparison of human syncytiotrophoblast brush border and basal plasma membranes. 1993 Sep-Oct Placenta pmid:8290492
Tomita Y et al. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. 1992 Pigment Cell Res. pmid:1292020
Anauate MC et al. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay. 2010 Phytother Res pmid:20812280
Park MK et al. Antiplatelet and antithrombotic activity of indole-3-carbinol in vitro and in vivo. 2008 Phytother Res pmid:17724769
Kang JW et al. Anti-platelet activity of erythro-(7S,8R)-7-acetoxy-3,4,3',5'-tetramethoxy-8-O-4'-neolignan from Myristica fragrans. 2013 Phytother Res pmid:23296979
Jin UH et al. Inhibitory effect of Panax notoginseng on nitric oxide synthase, cyclo-oxygenase-2 and neutrophil functions. 2007 Phytother Res pmid:17128437
Chandrasekaran CV et al. Dual inhibitory effect of Glycyrrhiza glabra (GutGardâ„¢) on COX and LOX products. 2011 Phytomedicine pmid:20864324
Williams CA et al. The flavonoids of Tanacetum parthenium and T. vulgare and their anti-inflammatory properties. 1999 Phytochemistry pmid:10382317
Broulík PD et al. Impact of antihypertensive therapy on the skeleton: effects of enalapril and AT1 receptor antagonist losartan in female rats. 2001 Physiol Res pmid:11551140
Taube C et al. [The effect of trapidil and the trapidil derivative AR 12463 on blood pressure and thromboxane formation in spontaneously hypertensive rats]. 1987 Pharmazie pmid:3671447
Zhou K et al. A CAPE analogue as novel antiplatelet agent efficiently inhibits collagen-induced platelet aggregation. 2014 Pharmazie pmid:25158573
Sziegoleit W et al. Serum thromboxane B2 after intravenous administration of talinolol and propranolol in healthy subjects. 1991 Pharmazie pmid:1677468
DeVries A et al. Ketoconazole in the prevention of acute respiratory distress syndrome. 1998 May-Jun Pharmacotherapy pmid:9620108
Greer IA Effects of ketorolac tromethamine on hemostasis. 1990 Pharmacotherapy pmid:2082316
Hart RG et al. Aspirin dosage and thromboxane synthesis in patients with vascular disease. 2003 Pharmacotherapy pmid:12741431
Canale P et al. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock. 1994 Pharmacology pmid:7878075
Subbiah MT et al. Enhancement of thrombocyte aggregation and thromboxane B2 synthesis by diethylstilbestrol. 1980 Pharmacology pmid:7220591
Gross GJ and Moore J Effect of COX-1/COX-2 inhibition versus selective COX-2 inhibition on coronary vasodilator responses to arachidonic acid and acetylcholine. 2004 Pharmacology pmid:15161995
Roth DM et al. Protective actions of ibuprofen in arachidonate-induced sudden death. 1983 Pharmacology pmid:6413987
Villalobos MA et al. Effects of camonagrel, a selective inhibitor of platelet thromboxane synthase, on the platelet-subendothelium interaction. 2003 Pharmacology pmid:12886030
Hui SC et al. Changes in arachidonic acid metabolite patterns in alloxan-induced diabetic rats. 1989 Pharmacology pmid:2515550
Kaehler S et al. S-ibuprofen effectively inhibits thromboxane B2 levels and platelet function in an experimental model of lipopolysaccharide-stimulated and non-stimulated whole blood. 2008 Pharmacology pmid:18043009
Sirois P et al. Role of cyclooxygenase products in the lung action of leukotrienes A4, B4, C4, D4 and E4. 1985 Pharmacology pmid:2997811
Serebruany VL et al. Mac-1 inhibitor affects certain hemostatic parameters during myocardial stunning in swine. 1996 Pharmacology pmid:8902873
Lo HM et al. 2'-Ethoxy-5'-methoxy-2-(5-methylthienyl)chalcone inhibits collagen-induced protein tyrosine phosphorylation and thromboxane formation during platelet aggregation and adhesion. 2009 Pharmacology pmid:19690443
Kim H et al. Effect of mannitol on Helicobacter pylori-induced cyclooxygenase-2 expression in gastric epithelial AGS cells. 2002 Pharmacology pmid:12393940
Kitzen JM et al. Failure of thromboxane synthetase inhibition to protect the postinfarcted heart against the induction of ventricular tachycardia and ventricular fibrillation in a conscious canine model of sudden coronary death. 1988 Pharmacology pmid:3227051
Belisario MA et al. In vitro effect of avarone and avarol, a quinone/hydroquinone couple of marine origin, on platelet aggregation. 1996 Pharmacol. Toxicol. pmid:9000256
Saareks V et al. Nicotinic acid and pyridoxine modulate arachidonic acid metabolism in vitro and ex vivo in man. 1999 Pharmacol. Toxicol. pmid:10401729
Naito Y et al. Increase in blood pressure with enhanced Na+, K+ -ATPase activity in stroke-prone spontaneously hypertensive rats after 4-weeks intake of rapeseed oil as the sole dietary fat. 2000 Pharmacol. Toxicol. pmid:11068856
Saareks V et al. Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. 2002 Pharmacol. Toxicol. pmid:12403056
Manninen A et al. Nifedipine increases urinary excretion of prostacyclin metabolite in hypertensive pregnancy. 1991 Pharmacol. Toxicol. pmid:1946195
Dahlin KL et al. Amitriptyline-induced release of endothelin-1 in isolated perfused and ventilated rat lungs. 1999 Pharmacol. Toxicol. pmid:10628905
Canale P et al. Splanchnic artery occlusion shock: vinblastine-induced leukopenia reduces tumour necrosis factor and thromboxane A2 formation, and increases survival rate. 1993 Jan-Feb Pharmacol. Res. pmid:8456059
Beretta C et al. COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis. 2005 Pharmacol. Res. pmid:15939622
Rossoni G et al. Nitric oxide and prostacyclin pathways: an integrated mechanism that limits myocardial infarction progression in anaesthetized rats. 2006 Pharmacol. Res. pmid:16488624
Saitta A et al. Effects of gallopamil on epinephrine and norepinephrine plasmatic levels and on TxB2 and beta-tg release in patients with coronary artery disease during adrenergic stimulus with cold pressor test. 1995 Jul-Aug Pharmacol. Res. pmid:8668647
Lee KS et al. Anti-platelet activity of KR-32560, a novel sodium/hydrogen exchanger-1 inhibitor. 2006 Pharmacol. Res. pmid:16420980
Paoletti R et al. Effects of coffee on plasma lipids, lipoproteins and apolipoproteins. 1989 Jan-Feb Pharmacol. Res. pmid:2726662
Facino RM et al. Phytochemical characterization and radical scavenger activity of flavonoids from Helichrysum italicum G. Don (Compositae). 1990 Nov-Dec Pharmacol. Res. pmid:2075159
Takami M and Tsukada W Correlative alteration of thromboxane A2 with antigen-induced bronchoconstriction and the role of platelets as a source of TXA2 synthesis in guinea pigs: effect of DP-1904, an inhibitor of thromboxane synthetase. 1998 Pharmacol. Res. pmid:9721601
Takami M and Tsukada W In vitro effect of DP-1904, a novel anti-asthma agent, against antigen-induced constriction and TXB2 release from the isolated guinea-pig lung parenchymal tissue. 1998 Pharmacol. Res. pmid:9721602
González-Correa JA et al. Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils. 2007 Pharmacol. Res. pmid:17644353
Bernareggi M et al. Bronchopulmonary effects of 8-epi-PGF2A in anaesthetised guinea pigs. 1998 Pharmacol. Res. pmid:9503483
Altavilla D et al. Protective effects of endotoxin tolerance in tumor bearing rats. 1992 Pharmacol. Res. pmid:1409293
Socini A et al. Effects of the coumarin derivative AD6 on platelet aggregation, platelet vessel wall interactions and 6 keto PGF1 alpha production in perfused aortas, in experimentally hypercholesterolaemic rabbits. 1982 Pharmacol Res Commun pmid:7048340
Galli C et al. Effects of 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy carboxyl methoxy coumarin (AD6) on aggregation, arachidonic acid metabolism and thromboxane B2 formation in human platelets. 1980 Pharmacol Res Commun pmid:7393988
Tarayre JP et al. Pharmacological modulation of PAF-acether-induced pleurisy in rats. 1987 Pharmacol Res Commun pmid:3448610
Berti F et al. The PAF-acether receptor antagonist BN-52021 inhibits mediator release during guinea-pig active lung anaphylaxis. 1988 Pharmacol Res Commun pmid:2463644
Magni F et al. BN-52021 protects guinea-pig from heart anaphylaxis. 1988 Pharmacol Res Commun pmid:3247358
Bertazzo A et al. Effects of gangliosides on the formation of eicosanoids in rat brain cerebral ischemia and reperfusion. 1988 Pharmacol Res Commun pmid:3247360
Masi I et al. Effects of CDP-choline on platelet aggregation and the antiaggregatory activity of arterial wall in the rat. 1986 Pharmacol Res Commun pmid:3523545
Csanyi G et al. Lack of endothelium-derived hyperpolarizing factor (EDHF) up-regulation in endothelial dysfunction in aorta in diabetic rats. 2007 Jul-Aug Pharmacol Rep pmid:17901574
Csányi G et al. Effects of 3-aminopyridine-induced seizures on platelet eicosanoid synthesis. 2008 May-Jun Pharmacol Rep pmid:18622059
Fujiwara T et al. Exploratory aspirin resistance trial in healthy Japanese volunteers (J-ART) using platelet aggregation as a measure of thrombogenicity. 2007 Pharmacogenomics J. pmid:17245331
Oh SH et al. Association analysis of thromboxane A synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients. 2011 Pharmacogenomics pmid:21449675
Suarez-Kurtz G Impact of CYP2C9*3/*3 genotype on the pharmacokinetics and pharmacodynamics of oxicam NSAIDs. 2014 Pharmacogenet. Genomics pmid:25003537
Lee HI et al. Response to Suarez-Kurtz's comments on strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals. 2014 Pharmacogenet. Genomics pmid:25003538
Chen CY et al. Functional analysis of human thromboxane synthase polymorphic variants. 2012 Pharmacogenet. Genomics pmid:22735388
Lee HI et al. Strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals. 2014 Pharmacogenet. Genomics pmid:24322170
Patrignani P et al. Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study. 2008 Pharmacogenet. Genomics pmid:18551041
Ammoury N et al. Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats. 1991 Pharm. Res. pmid:2014197
Shimizu T et al. Up-regulation of Kv7.1 channels in thromboxane A2-induced colonic cancer cell proliferation. 2014 Pflugers Arch. pmid:23995773
Mathie RT et al. The haemodynamic effects of the thromboxane A2 receptor antagonist GR32191B during cardiopulmonary bypass in the dog. 1995 Perfusion pmid:8747897
Bayorh MA et al. 1A-779 attenuates angiotensin-(1-7) depressor response in salt-induced hypertensive rats. 2002 Peptides pmid:11814618
Brus F et al. Number and activation of circulating polymorphonuclear leukocytes and platelets are associated with neonatal respiratory distress syndrome severity. 1997 Pediatrics pmid:9113943
Stuart MJ and Allen JB Arachidonic acid metabolism in the neonatal platelet. 1982 Pediatrics pmid:6804924
Stuart MJ et al. Effects of hyperoxia and hypoxia on vascular prostacyclin formation in vitro. 1984 Pediatrics pmid:6435087
Gerrard JM et al. A role for prostacyclin in bruising symptomatology. 1992 Pediatrics pmid:1614775
Stuart MJ et al. Changes in oxygen tension and effects on cyclooxygenase metabolites: III. Decrease of retinal prostacyclin in kittens exposed to hyperoxia. 1988 Pediatrics pmid:3136433
Setty BN et al. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids. 1995 Pediatr. Res. pmid:7478805
Kühl PG et al. Increased renal biosynthesis of prostaglandin E2 and thromboxane B2 in human congenital obstructive uropathy. 1990 Pediatr. Res. pmid:2296464
Goldberg RN et al. Effects of a leukotriene antagonist on the early hemodynamic manifestations of group B streptococcal sepsis in piglets. 1986 Pediatr. Res. pmid:3534778
Runkle B et al. Cardiovascular changes in group B streptococcal sepsis in the piglet: response to indomethacin and relationship to prostacyclin and thromboxane A2. 1984 Pediatr. Res. pmid:6384909
Israels SJ et al. Deficient thromboxane synthesis and response in platelets from premature infants. 1997 Pediatr. Res. pmid:9029642
Peevy KJ et al. Prostaglandin synthetase inhibition in group B streptococcal shock: hematologic and hemodynamic effects. 1986 Pediatr. Res. pmid:3092176
Stuart MJ et al. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine. 1984 Pediatr. Res. pmid:6435080
Leffler CW et al. Ischemia alters cerebral vascular responses to hypercapnia and acetylcholine in piglets. 1989 Pediatr. Res. pmid:2919133
Mischler EH et al. Correction of linoleic acid deficiency in cystic fibrosis. 1986 Pediatr. Res. pmid:3456148
Israels SJ et al. Deficient collagen-induced activation in the newborn platelet. 1990 Pediatr. Res. pmid:2111540
Shook LA et al. Group B streptococcus promotes oxygen radical-dependent thromboxane accumulation in young piglets. 1990 Pediatr. Res. pmid:2111541
Truog WE et al. Neonatal group B streptococcal sepsis: effects of late treatment with dazmegrel. 1988 Pediatr. Res. pmid:3287320
Engelhardt B et al. The role of granulocytes in the pulmonary response to group B streptococcal toxin in young lambs. 1987 Pediatr. Res. pmid:3822595
Aziz SM et al. Intrinsic microbicidal activity and pulmonary hypertension in isolated newborn piglet lungs. 1993 Pediatr. Res. pmid:8356015